PDB50 INCREASED HOSPITALIZATIONS BY CHILDREN WITH TYPE 2 DIABETES
Kim SH Florida International University, Miami, FL, USA OBJECTIVE: Type 2 diabetes has been reported with increasing frequency among children aged 17 or younger (hereafter referred to as "children") in the United States (US). However, while it is known that the prevalence of type 2 diabetes among children is growing, there is little information about their hospital use. This study is purposed to study the trend of hospitalizations with type 2 diabetes among children between the year 1997 and 2003 in the US. METHODS: The study was based on the Kids Inpatient Database (KID), a nationally representative probability sample sponsored by the Agency of Health Research and Quality (AHRQ). The KID, a database of hospital stays for children, includes annually two million to three million pediatric inpatient records selected from over 2500 to 3500 US community hospitals. RESULTS: The numbers of hospitalization made by children with type 2 diabetes were 2209, 4232, and 5840 in the year 1997, 2000, 2003, respectively . Adjusting for the growth of population size, the rate of hospitalization with type 2 diabetes was 2.5 times larger in 2003 compared to 1997. During the same time period, the number of hospitalization made by children with type 1 diabetes was 33,504, 35,541, and 36,439 . This growth of the hospitalization rate was the same as that of the children population in US. Therefore, adjusting for the population size, the rate of hospitalization with type 1 diabetes remained the same. CONCLUSION: Given that the symptoms of type 2 diabetes take a long time to develop, even small numbers of hospitalizations are alarming. Furthermore, unlike that of type 1 diabetes, the hospitalization with type 2 diabetes was rapidly on the rise. With a continuous increase in obesity among children, the burden of type 2 diabetes is a growing public health concern. Patients were included if they had diagnosis of diabetes, received at least 1 diabetes medication and were continuously enrolled during the study period. Medication adherence rates were measured as percentage of days that the patient possessed any available diabetic drug from July 1, 2005 to July 1, 2006. Each study member was placed into 1 of 3 mutually exclusive adherence category, defined as 0 Յ MPR < 0.5 (non-adherent group), 0.5 Յ MPR < 0.8 (partially adherent group), 0.8 Յ MPR Յ 1 (adherent group). Descriptive analyses were conducted within each category to assess the patient characteristics and health care costs; Multivariate regression models were conducted to determine the impact of adherence on the health care costs controlling for confounding factors. RESULTS: A total of 4262 patients were included. Non-adherent, partially-adherent and adherent patients accounts for 12.9%, 19.1% and 68.2% respectively. The average diabetes-related medical care costs in the 18 months post-index period decreased as the adherence level increased. The average overall medical care costs in the 18 months post-index period also decreased as the adherence level increased. The average overall health care costs of partially adherent group and adherent group are both lower than non-adherent group. After controlling for patient characteristics, comorbidities, and health care cost in the six months pre-index period the multivariate regression showed low drug adherence level was significant predictors of both higher diabetes-related medical care costs (p < 0.0001) and higher overall total medical care cost costs (p < 0.001). CONCLUSION: Non-adherent diabetic patients have higher diabetes-related and overall medical care cost than partially adherent diabetic patients and adherent diabetic patients. Investment in disease management programs to promote adherence with medication regimen may needed for these non-adherent diabetic patients.
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